标准简介
FDA 510(k) 是美国医疗器械最常见的上市前提交途径，以《联邦食品、药品和化妆品法案》第 510(k) 节命名。510(k) 批准证明新器械与合法上市的前置器械「实质等同」——即具有相同的预期用途和类似的技术特性，或即使不同，也不会引起新的安全性和有效性问题。由 FDA 器械和放射健康中心（CDRH）管理，510(k) 程序涵盖大多数 II 类医疗器械和一些未豁免上市前通知的 I 类器械。每年约有 3,000-4,000 份 510(k) 提交接受审查。
510(k) 提交过程要求确定适当的前置器械，准备显示实质等同的比较，进行性能测试（生物相容性、电磁兼容性、软件验证等），并将材料提交给 FDA。存在三种类型的 510(k)：传统型（最全面）、特殊型（用于充分理解的器械修改）和简化型（利用公认的共识标准或 FDA 指南）。FDA 审查时间通常为受理后 90 天，但实际批准通常需要 3-12 个月，包括提交前交流。2023 年，FDA 推出了预定变更控制计划途径，允许制造商在原始提交中描述预期的器械修改，减少未来 510(k) 的需要。与 EU MDR 的主要区别包括基于前置器械的方法（而非基于风险）、通常需要较少的临床数据，以及没有强制性的质量体系认证——尽管预期遵守 FDA 的质量体系法规（21 CFR 820）。
Substantial Equivalence
The core of 510(k) — demonstrate your device is substantially equivalent to a legally marketed predicate device in intended use, technology, and performance.
Average 100-Day Review
FDA targets a 90-day review cycle for Traditional 510(k) submissions. Actual average clearance time is approximately 100 days, not counting RTA hold times.
Three Submission Types
Traditional 510(k) for standard comparisons, Special 510(k) for modifications to your own device, and Abbreviated 510(k) using guidance documents or special controls.
list_alt Key Submission Elements
- Predicate device comparison and substantial equivalence argument
- Device description and intended use
- Performance testing (bench, biocompatibility, software)
- Labeling including indications for use
- Sterilization validation (if applicable)
- Biocompatibility assessment per ISO 10993
- Electrical safety and EMC testing (if applicable)
- 510(k) summary or 510(k) statement
Who Needs to Comply?
Manufacturers of Class II medical devices (and some Class I and Class III devices) intended for the US market. Required before commercially distributing a new device or a device with significant changes to design or intended use.
Key Requirements
Predicate Device Selection
Identify a legally marketed predicate device with the same intended use and similar technological characteristics. The predicate must have a valid 510(k) clearance, pre-amendment status, or De Novo classification.
Substantial Equivalence Testing
Conduct performance testing to demonstrate your device is as safe and effective as the predicate. Testing scope depends on differences — may include bench testing, animal studies, biocompatibility, software validation, and/or clinical data.
Quality System Compliance
Maintain a Quality Management System compliant with 21 CFR Part 820 (Quality System Regulation). FDA may inspect your facility before or after clearance. Design controls are required for Class II devices.
Post-Market Requirements
Register your establishment and list devices with FDA annually. Report adverse events via MDR (Medical Device Reporting). Implement corrections and removals when necessary and report to FDA.
Penalties & Enforcement
Marketing a device without required 510(k) clearance is a violation of the Federal Food, Drug, and Cosmetic Act. FDA can issue Warning Letters, seize products, seek injunctions, and pursue criminal prosecution. Civil monetary penalties up to $17,730 per violation per day.